Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-006642
Filing Date
2024-11-14
Accepted
2024-11-14 19:48:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 CORBUS PHARMACEUTICALS HOLDINGS, INC. p24-3154sc13ga.htm SC 13G/A 54772
  Complete submission text file 0000902664-24-006642.txt   56407
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Subject) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88716 | Film No.: 241465286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A